China's Beauty Market Is Growing Again — But Not for Imports: A Deep Dive for Western Beauty Brands

The data floor: a recovering market, a shrinking import share

The structural picture: overall demand is healthy, volume is migrating to domestic brands at mass and premium-mid price points, and the import survivors are concentrating at the very top of the price ladder. The middle of the import market — decent foreign brands at mid prices — is being eaten from both sides.

Country-by-country: your passport matters less than your category

• France holds the #1 supplier position (29.6% share of beauty imports; USD 4.79B in 2025, +5.1%) on the strength of luxury skincare and fragrance. French-origin prestige still commands trust.
• The United States is the surprise: +38.6% import growth in June 2026 — the strongest of any major supplier — riding demand for functional, dermatologist-backed, "clinical" skincare.
• Japan and Korea are in visible retreat: Korean imports −11.2%, Japanese −8.4% (June 2026), and roughly 30 international beauty brands closed or exited China in 2025, nearly 80% of them Japanese or Korean. The 2016-era K-beauty playbook is not your playbook.
• In marketplace brand-level terms, French brands lead online GMV (16.12% of top-1000 brand sales), then US (11.74%), Japan (6.39%), Korea (4.00%).

Read that list again as an entry-brief: where you are from now determines which lane is open. US brands with clinical/functional positioning are entering the friendliest window in years; French prestige remains structurally strong; mid-priced Japanese and Korean brands face the hardest decade since the market opened.

Where the actual opportunities are

1. Fragrance — the fastest-growing beauty category, and the most foreign-friendly.

Fragrance is now China's fastest-growing beauty sub-category, ahead of skincare and color. The buyer base has widened beyond mature luxury consumers to younger, gender-mixed audiences treating scent as identity rather than status signaling. Critically, it is one of the few segments where heritage international houses still hold clear pricing and trust advantages over domestic challengers. For a mid-sized niche-fragrance brand, this is the best entry lane in beauty today.

2. Clinical and "proof-led" positioning.

Chinese consumers have moved decisively past "natural" as a trust signal: they want the mechanism, the concentration, and the test data. A brand that can show clinical evidence, specific actives, and testable claims holds an edge that domestic challengers find expensive to replicate — this is what is powering the US import surge. "Botanical" without backup is now a lagging claim, not a premium one.

3. Premium-luxury, not premium-middle.

The premium band (roughly CNY 360–1,080 online) fell 11.6% in H1 2026 while luxury (above CNY 1,080) grew 9.1%. The squeezed middle is where import brands have historically clustered; the defensible price positions are now at the two ends — and for imports, the luxury end is the one that works.

4. Content commerce, where the beauty volume is.

On established marketplaces, international brands still held ~66% of premium skincare bestseller sales in 2025; on content-led commerce (Douyin), Chinese brands held 80%. Douyin beauty category GMV is now roughly twice Tmall's makeup category size on industry measures — the beauty battleground has moved. A Western beauty brand that enters without a content-commerce plan is entering the market of 2021, not 2026.

5. China-specific white spaces.

Lip care with actives, scalp care ("skinification" of hair), men's grooming, and medical-aesthetics-adjacent skincare are all newly-formed categories where consumer search behavior is only 1–2 years old and no brand has cemented authority. New categories are where new entrants — foreign or domestic — actually get openings.

What this means for a $50-100M brand

• Do not enter as a generalist. The import halo is gone; a mid-sized brand must enter with one defensible wedge — a clinical hero product, a niche fragrance line, or a white-space category — rather than a full catalog.
• Price high or go home. Model your China entry at the luxury/premium-luxury band, where imports still hold share and the quota relaxation (CNY 8,000 per order) removed the structural ceiling. The mid-band is a knife fight with C-beauty on price and speed.
• Budget content as infrastructure, not promotion. Between Xiaohongshu research behavior and Douyin's channel dominance, the content layer is the market. Your US social budget proportions are the wrong template for China.
• Verify your origin story works for you. US + clinical or French + prestige = tailwind. Mid-priced Japanese/Korean positioning = structural headwind that no media budget fixes.

Our take

If we were placing a mid-sized Western beauty brand into China in 2027, the brief we'd write for it: one hero SKU with a clinically-provable claim, priced into the luxury band, a fragrance or scalp/lip white-space adjacent to the hero, a Xiaohongshu seeding program of 60+ mid/tail notes to prove the claim language, a Tmall Global flagship to capture the search demand — and a Douyin content-commerce plan as the year-two growth engine, staffed and budgeted from day one, not bolted on later. The era when being foreign was the strategy is over. The brands that win from here are the ones that treat China as their most demanding market, not their easiest one.

Sources

1. National Bureau of Statistics of China — cosmetics retail sales, 2025–2026.
2. General Administration of Customs of China — cosmetics import values by origin, 2025–2026.
3. China Cosmetics Association (香妆协会) — domestic vs. import brand share, 2020–2026.
4. Moojing Market Intelligence — premium/luxury skincare price-tier and brand-origin analysis, H1 2026.
5. Euromonitor International — premium beauty share estimates, 2026.
6. Industry trackers (FBeauty, 聚美丽 and related trade coverage) — brand exits and category trends, 2025–2026.
7. Douyin and platform category data — channel GMV measures, 2024–2026.
8. Resonate Consulting analysis.

Disclaimer: This article draws on a wide range of industry research reports and publicly available sources. If any content infringes upon the intellectual property rights of any individual or organization, please contact us promptly and we will address it immediately.